Researches

Displaying 271 - 280 of 4042
# Title Department Research Year
271 Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents Department of Pharmaceutical Organic Chemistry 2023
272 Design, synthesis, antiproliferative actions, and DFT studies of new bis-pyrazoline derivatives as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2023
273 Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3-(2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFRWT/EGFRT790M inhibitors Department of Pharmaceutical Organic Chemistry 2023
274 Design, synthesis, docking and mechanistic studies of new thiazolyl/thiazolidinylpyrimidine-2,4-dione antiproliferative agents Department of Pharmaceutical Organic Chemistry 2023
275 Development of a highly sensitive and eco‑friendly high‑performance thin‑layer chromatography approach for the determination of empagliflozin, pioglitazone, and rosuvastatin simultaneously in pharmaceutical preparations and different biological fluids Department of Pharmaceutical Analytical Chemistry 2023
276 Development of oral formulation of Lepidium seeds significantly decreases the high blood glucose levels in diabetic rats: in vitro formulation and in vivo antidiabetic performance 2023
277 Development of sensitive spectrofluorometric approach based on formation of pyrrolidone derivative for determination of linagliptin through condensation reaction with ninhydrin and phenylacetaldehyde: Application to content uniformity and real plasma Department of Pharmaceutical Analytical Chemistry 2023
278 Discovery and optimization of 2, 3-diaryl-1, 3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity Department of Pharmaceutical Organic Chemistry 2023
279 Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity Department of Pharmaceutical Organic Chemistry 2023
280 Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action Department of Pharmaceutical Organic Chemistry 2023